What is the effect of adjusting epirubicin doses for body surface area?

Por Dobbs, N. A., Twelves, C. J.
Publicado em 1998

Anthracycline doses in patients with liver dysfunction: do UK oncologists follow current recommendations?

Por Dobbs, N. A., Twelves, C. J.
Publicado em 1998

Clinical pharmacokinetics of epirubicin: the importance of liver biochemistry tests.

Por Twelves, C. J., Dobbs, N. A., Michael, Y., Summers, L. A., Gregory, W., Harper, P. G., Rubens, R. D., Richards, M. A.
Publicado em 1992

A phase II, multicentre, UK study of vinorelbine in advanced breast cancer.

Por Twelves, C. J., Dobbs, N. A., Curnow, A., Coleman, R. E., Stewart, A. L., Tyrrell, C. J., Canney, P., Rubens, R. D.
Publicado em 1994

Iododoxorubicin in advanced breast cancer: a phase II evaluation of clinical activity, pharmacology and quality of life.

Por Twelves, C. J., Dobbs, N. A., Lawrence, M. A., Ramirez, A. J., Summerhayes, M., Richards, M. A., Towlson, K. E., Rubens, R. D.
Publicado em 1994

Phosphorus-31 metabolism of post-menopausal breast cancer studied in vivo by magnetic resonance spectroscopy.

Por Twelves, C. J., Porter, D. A., Lowry, M., Dobbs, N. A., Graves, P. E., Smith, M. A., Rubens, R. D., Richards, M. A.
Publicado em 1994